| Literature DB >> 24023791 |
Delér Shakely1, Kristina Elfving, Berit Aydin-Schmidt, Mwinyi I Msellem, Ulrika Morris, Rahila Omar, Xu Weiping, Max Petzold, Bryan Greenhouse, Kimberly A Baltzell, Abdullah S Ali, Anders Björkman, Andreas Mårtensson.
Abstract
BACKGROUND: We assessed if histidine-rich-protein-2 (HRP2) based rapid diagnostic test (RDT) remains an efficient tool for Plasmodium falciparum case detection among fever patients in Zanzibar and if primary health care workers continue to adhere to RDT results in the new epidemiological context of low malaria transmission. Further, we evaluated the performance of RDT within the newly adopted integrated management of childhood illness (IMCI) algorithm in Zanzibar. METHODS ANDEntities:
Mesh:
Year: 2013 PMID: 24023791 PMCID: PMC3762850 DOI: 10.1371/journal.pone.0072912
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Study flow chart.
(BS = blood smear, FP = filter paper, PCR = polymerase chain reaction.).
Baseline characteristics.
| RDT + | RDT − | Total (N) | ||
|
| North A | 42 (34.7%) | 2182 (57.9%) | 2224 |
| Micheweni | 79 (65.3%) | 1586 (42.1%) | 1665 | |
|
| 5 y | 36 (29.8%) | 1786 (47.4%) | 1822 |
| 5–14 y | 32 (26.4%) | 496 (13.2%) | 528 | |
| >14 y | 53 (43.8%) | 1472 (39.1%) | 1525 | |
| Data missing | 0 | 14 (0.3%) | 14 | |
|
| Male | 65 (53.7%) | 1611 (42.8%) | 1676 |
| Female | 56 (46.3%) | 2156 (57.2%) | 2212 | |
| Data missing | 0 | 2 (100%) | 2 | |
|
| 3 (2.5%) | 87 (2.3%) | 90 | |
|
|
|
| ||
|
| 38.3 | 37.4 | <0.001 | |
|
| 74 (66.7%) | 1465 (41.5%) | <0.001 | |
|
| 10 (8.3%) | 240 (6.4%) | 0.350 | |
|
| 65 (53.7%) | 3193 (84.7%) | <0.001 | |
|
| ≤28 days | 30 (24.8%) | 356 (9.5%) | <0.001 |
| Domestic | 21 (17.4%) | 325 (8.6%) | 0.003 | |
| Abroad | 9 (7.4%) | 31 (0.8%) | <0.001 |
Domestic = History of travel within Zanzibar.
Abroad = History of travel outside Zanzibar.
ITN = Insecticide-treated nets.
LLIN = long-lasting insecticidal nets.
Distribution of P. falciparum positive rapid diagnostic test (RDT), polymerase chain reaction (PCR) and blood smear (BS) microscopy results as well as microscopy determined parasite density across age groups.
| Age groups | Total | |||
| <5 y n = 1822 | 5–14 y n = 528 | >14 y n = 1525 | ||
| RDT + | 36 (2.0%) | 32 (6.1%) | 53 (3.5%) | 121 |
| PCR + | 34 (1.9%) | 34 (6.4%) | 56 (3.7%) | 124 |
| BS + | 31 (1.7%) | 33 (6.3%) | 52 (3.4%) | 116 |
| Geometric mean parasite density/µL (range) | 13815 (50–597,500) | 14172 (12–782,400) | 3739 (6–184,500) | |
Data on specific age categories (5–14 y and >14 y) were missing from14 patients.
Rapid diagnostic test (RDT) sensitivity, specificity, positive and negative predictive value against polymerase chain reaction (PCR) and blood smear (BS) microscopy.
| PCR + | PCR – | Total | BS+ | BS− | Total | |
| RDT + | 117 | 4 | 121 | 110 | 11 | 121 |
| RDT – | 7 | 726 | 733 | 6 | 733 | 739 |
| Total | 124 | 730 | 854 | 116 | 744 | 860 |
| Sensitivity | 76.5% (95% CI 69.0– 83.9%) | 78.6% (95% CI 70.8–85.1) | ||||
| Specificity | 99.9% (95% CI 99.7– 100%) | 99.7% (95% CI 99.5–99.9%) | ||||
| Positive predictive value | 96.7% (95% CI 91.8– 99.1%) | 91.7% (95% CI 84.3–95.4%) | ||||
| Negative predictive value | 99.0% (95% CI 98.0– 99.6%) | 99.2% (95% CI 98.8–99.5%) | ||||
For calculations of sensitivity and specificity the absolute numbers in the RDT negative group were multiplied with a factor of 5.14 to account for that only a sub-sample, i.e. 733 of 3768, in this group were subjected to blood sampling on filter paper for PCR.
For calculations of sensitivity and specificity the absolute numbers in the RDT negative group were multiplied with a factor of 5.01 to account for that only a sub-sample, i.e. 739 of 3768, in this group were subjected to blood sampling for BS microscopy.
Prescription of anti-malarial medicines, antibiotics and antipyretics by rapid diagnostic test (RDT) result and age group.
| Prescription | Age | RDT + | RDT − | P-value |
|
| <5 y | 36/36 (100%) | 0/1786 (0%) | <0.001 |
| 5–14 y | 32/32 (100%) | 0/496 | <0.001 | |
| >14 y | 53/53 (100%) | 3/1472 | <0.001 | |
|
| <5 y | 20/36 (55.6%) | 1032/1786 (57.8%) | >0.999 |
| 5–14 y | 8/32 (25.0%) | 341/496 | <0.001 | |
| >14 y | 6/53 (11.3%) | 804/1472 | <0.001 | |
|
| <5 y | 14/36 (38.9%) | 437/1786 (24.5%) | 0.053 |
| 5–14 y | 19/32 (59.4%) | 278/496 | 0.855 | |
| >14 y | 34/53 (64.2%) | 894/1472 | 0.669 |
Data on specific age categories (5–14 y and >14 y) were missing from14 patients.